HealthEquity Inc
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It provides health savings accounts; investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. The company also offers flexible spending accounts for health and dependent care; health reimbursement arrangements; and Consolidated Om… Read more
HealthEquity Inc (HQY) - Net Assets
Latest net assets as of October 2025: $2.13 Billion USD
Based on the latest financial reports, HealthEquity Inc (HQY) has net assets worth $2.13 Billion USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($3.40 Billion) and total liabilities ($1.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.13 Billion |
| % of Total Assets | 62.8% |
| Annual Growth Rate | 39.79% |
| 5-Year Change | 53.4% |
| 10-Year Change | 939.49% |
| Growth Volatility | 86.81 |
HealthEquity Inc - Net Assets Trend (2013–2025)
This chart illustrates how HealthEquity Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for HealthEquity Inc (2013–2025)
The table below shows the annual net assets of HealthEquity Inc from 2013 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | $2.11 Billion | +3.93% |
| 2024-01-31 | $2.04 Billion | +7.35% |
| 2023-01-31 | $1.90 Billion | +2.32% |
| 2022-01-31 | $1.85 Billion | +34.37% |
| 2021-01-31 | $1.38 Billion | +33.82% |
| 2020-01-31 | $1.03 Billion | +115.96% |
| 2019-01-31 | $477.08 Million | +37.77% |
| 2018-01-31 | $346.27 Million | +32.20% |
| 2017-01-31 | $261.94 Million | +28.74% |
| 2016-01-31 | $203.46 Million | +41.20% |
| 2015-01-31 | $144.09 Million | +323.71% |
| 2014-01-31 | $34.01 Million | -10.50% |
| 2013-01-31 | $38.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to HealthEquity Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 22834300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $209.27 Million | 9.90% |
| Common Stock | $9.00K | 0.00% |
| Other Components | $1.91 Billion | 90.10% |
| Total Equity | $2.11 Billion | 100.00% |
HealthEquity Inc Competitors by Market Cap
The table below lists competitors of HealthEquity Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hang Lung Properties Ltd
PINK:HLPPY
|
$6.66 Billion |
|
Hormel Foods Corporation
NYSE:HRL
|
$6.66 Billion |
|
NOV Inc.
NYSE:NOV
|
$6.66 Billion |
|
BILIBILI INC. DL -0001
F:71BB
|
$6.66 Billion |
|
Nippon Sanso Holdings Corporation
PINK:TYNPF
|
$6.65 Billion |
|
PT Barito Renewables Energy Tb
JK:BREN
|
$6.65 Billion |
|
ANTERO MIDSTREAM DL -01
F:5711
|
$6.65 Billion |
|
Uranium Energy Corp
NYSE MKT:UEC
|
$6.64 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in HealthEquity Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,035,021,000 to 2,114,911,000, a change of 79,890,000 (3.9%).
- Net income of 96,703,000 contributed positively to equity growth.
- Share repurchases of 121,493,000 reduced equity.
- Other factors increased equity by 104,680,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $96.70 Million | +4.57% |
| Share Repurchases | $121.49 Million | -5.74% |
| Other Changes | $104.68 Million | +4.95% |
| Total Change | $- | 3.93% |
Book Value vs Market Value Analysis
This analysis compares HealthEquity Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.33x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 102.24x to 3.33x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-01-31 | $0.78 | $79.40 | x |
| 2014-01-31 | $0.75 | $79.40 | x |
| 2015-01-31 | $2.78 | $79.40 | x |
| 2016-01-31 | $3.46 | $79.40 | x |
| 2017-01-31 | $4.37 | $79.40 | x |
| 2018-01-31 | $5.60 | $79.40 | x |
| 2019-01-31 | $7.53 | $79.40 | x |
| 2020-01-31 | $15.05 | $79.40 | x |
| 2021-01-31 | $18.22 | $79.40 | x |
| 2022-01-31 | $22.28 | $79.40 | x |
| 2023-01-31 | $22.45 | $79.40 | x |
| 2024-01-31 | $23.40 | $79.40 | x |
| 2025-01-31 | $23.81 | $79.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently HealthEquity Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.06%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 1.63x
- Recent ROE (4.57%) is below the historical average (7.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 31.37% | 24.23% | 1.00x | 1.30x | $7.61 Million |
| 2014 | 3.63% | 1.99% | 1.13x | 1.62x | $-2.17 Million |
| 2015 | 7.06% | 11.57% | 0.55x | 1.10x | $-4.24 Million |
| 2016 | 8.17% | 13.10% | 0.58x | 1.08x | $-3.73 Million |
| 2017 | 10.07% | 14.79% | 0.64x | 1.07x | $182.00K |
| 2018 | 13.68% | 20.63% | 0.62x | 1.07x | $12.73 Million |
| 2019 | 15.49% | 25.73% | 0.56x | 1.07x | $26.19 Million |
| 2020 | 3.85% | 7.46% | 0.21x | 2.49x | $-63.37 Million |
| 2021 | 0.64% | 1.20% | 0.27x | 1.97x | $-129.04 Million |
| 2022 | -2.39% | -5.85% | 0.24x | 1.68x | $-229.55 Million |
| 2023 | -1.38% | -3.03% | 0.28x | 1.63x | $-215.71 Million |
| 2024 | 2.74% | 5.57% | 0.32x | 1.55x | $-147.79 Million |
| 2025 | 4.57% | 8.06% | 0.35x | 1.63x | $-114.79 Million |
Industry Comparison
This section compares HealthEquity Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| HealthEquity Inc (HQY) | $2.13 Billion | 31.37% | 0.59x | $6.65 Billion |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |